Genzyme

Two top BioMed officials told investors that stronger activity at two nearly-completed Northeast projects and a stash of cash will enable it to continue paying customary dividends, though conceded a slowdown in Bay Area leasing.

A little more than a month after inking a deal with Genzyme that will provide the firm with a $24.5 million cash infusion, Exact Sciences has been told by Nasdaq that it is not in compliance with a listing regulation.

The International Brotherhood of Electrical Workers launched its Stop Biotech Looting campaign last week after learning that subcontractors have been hiring non-union workers over the past year on a half-dozen projects for Boston-area life-sci giants.

Snippets

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Though the budget would raise by one-third, or to $20 million, the state's maximum annual outlay to life-sci center grants covered by the Commonwealth Life Sciences Investment Program, it still falls short of the $25 million annual limit set by the Massachusetts Life Sciences Act.

Christian Johansson, Gov. Martin O'Malley, Ambrose Schwallie, Jonathan Fleming, Doug Cole, Jean George, Christopher Schaber, Paul Alivisatos, Steve Chu, President Barack Obama, Jay Keasling, Greg Kessler, Jeffrey New

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.